arrow
T

Talal El Zarif

yale cancer center
H指数:20
被引数:1,302

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

74 HIF2α Downregulation and Clinical Outcomes in Patients with Clear Cell Renal Cell Carcinoma with and without Sarcomatoid Differentiation

74 HIF2α低表达及有无肉瘤样分化的透明细胞肾细胞癌患者的临床结局

2026-09-020
OAAI
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study

免疫疗法在伴有心包积液的晚期NSCLC中的有效性和安全性:一项全球回顾性多中心研究

2026-07-250
OAAI
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性

2025-10-160
OAAI
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study

免疫检查点疗法治疗心脏转移患者的安全性与有效性:一项多中心国际回顾性研究

2025-03-031
OA
Association between baseline radiological tumor burden (BRTB) and outcomes in metastatic clear cell renal cell carcinoma (mccRCC) treated with first line (1L) immunotherapy (IO)-based regimens

基线放射学肿瘤负荷(BRTB)与接受一线(1L)免疫治疗(IO)方案治疗的转移性透明细胞肾细胞癌(mccRCC)患者预后的关系

2024-09-010
PRE
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma

肉瘤样分化的表观基因组特征指导肾细胞癌的治疗

2024-06-010
OA
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
2024-03-050
OAAI
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study

癌症转移对新型冠状病毒肺炎结局的影响: 基于新型冠状病毒肺炎和癌症协会注册的回顾性队列研究

CANCER
IF5.1
2024-02-200
PRE
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study
2024-02-012
OA
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database

国际转移性肾细胞癌数据库中西班牙裔和非西班牙裔晚期肾细胞癌患者结局的比较

CANCER
IF5.1
2024-01-312
PRE
Liquid biopsy epigenomic profiling for cancer subtyping (vol 29, pg 2737, 2023)
2023-12-041
OAAI
Biomarker benchmarking across ancestral populations

跨祖先人群的生物标志物基准

2023-12-010
PRE
Liquid biopsy epigenomic profiling for cancer subtyping

用于癌症亚型的液体活检表观基因组分析

2023-10-2125
OAAI